Clinical TrialsSearch results
Number of results: 2560
Other
- Multicenter Before-After Study of Dignity Therapy for Japanese Cancer Patients
- Advanced and/or terminally ill cancer
- Nagoya City University
- 2008-04-30
Other
- Randomized phase II study comparing Gemcitabine versus TS-1 for advanced bile duct cancer
- Advanced bile duct cancer
- Osaka International Cancer Institute Department of Hepatobiliary and pancreatic Oncology
- 2008-12-22
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine in advanced biliary tract cancer (GS-COMBI).
- Advanced biliary tract cancer
- Japanese Endoscopist & IVRists group for Biliary Tract Cancer (JEIBIC)
- 2009-02-12
Other
- The efficacy and safety of gemcitabine / cisplatin combination therapy in patients with advanced refractory biliary tract cancer
- Advanced biliary tract cancer refractory to gemcitabine and S-1
- Faculty of Medicine, University of Tokyo
- 2009-01-03
Recruiting
- A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)
- Advanced Breast Cancer
- Hibi Kazushige
- 2024-05-20
Other
- Phase 1/2 Study of BLU-451 in Advanced Cancers with EGFR Exon 20 Insertion Mutations
- Advanced cancer with EGFR Exon 20ins Mutations
- Zalutskaya Alena
- 2022-10-18
Other
- randomized trial for the efficacy of primary prophylaxis with granulocyte colony stimulating factor in advanced childhood mature B-cell malignancies
- advanced childhood mature B-cell malignancies
- Japan Pediatric Leukemia/Lymphoma Study Group
- 2007-04-11
Other
- Phase II study of S-1 combined with irinotecan in patients with advanced colorectal cancer
- Advanced colorectal cancer
- Showa University School of Medicin
- 2009-02-28
Other
- Phase I clinical study of peptide vaccine using novel tumor-associated antigen TTK against advanced esophageal carcinoma
- Advanced esophageal cancer refractory to standard therapeutic modality
- University of Tokyo
- 2008-02-04
Other
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil; OK-432 and Montanide; ISA-51 in patients with cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2008-07-24